Findings showed meloxicam/rizatriptan statistically significantly improved migraine treatment response compared with prior oral CGRP inhibitor treatment. Topline data were announced from a phase 3 ...

The approval of medicines called “CGRP antagonists” has led to big changes in how migraines are managed. These medicines work in a different way than older medicines to treat or prevent migraine. The ...

A potential first-in-class therapy for migraine prevention has shown promise in a phase 2a proof-of-concept study, with a single infusion reducing migraine frequency over 4 weeks. The drug Lu AG09222 ...

Calcitonin gene-related peptide (CGRP) inhibitors -- a group of drugs commonly used to treat migraine -- were associated with decreased rates of acne and rosacea compared with drugs that did not ...

The approval of medicines called CGRP antagonists has led to big changes in how migraine is managed. These medicines work in a different way than older medicines to treat or prevent migraine. The ...

WhatAreMigraines.com launches as a neurologist-authored platform providing science-backed education on migraine treatments including CGRP inhibitors and Botox, addressing a critical gap in accessible, ...

For Cherise Irons, chocolate, red wine, and aged cheeses are dangerous. So are certain sounds, perfumes and other strong scents, cold weather, and thunderstorms. Stress and lack of sleep, too. She ...

Neurologist Dr. Susan Lee answers common questions about new treatments for migraine and where the future of migraine research is headed. Standard treatments taken at the onset of a migraine episode ...

Anti-calcitonin gene-related peptide monoclonal antibodies (mAbs) demonstrated meaningful and sustained effectiveness in reducing monthly migraine days (MMDs) across three consecutive 1-year treatment ...

Please provide your email address to receive an email when new articles are posted on . A majority of patients had initial or sustained significant symptom improvement, with few adverse effects. Most ...

Researchers at Harvard Medical School have found that blocking the neuron-released peptide CGRP decreases pain sensitivity and reduces lesion size in endometriosis. Endometriosis is a painful, steroid ...